In two trimethylsilyl-substituted 1H-benzimidazole-2(3H)-thiones, noncovalent C—H⋯π interactions between the centroid of the benzmidazole system and the SiMe3 groups form helicoidal arrangements in one, and dimerization results in the formation of
(8) rings via N—H⋯S interactions, along with parallel π–π interactions between imidazole and benzene rings, in the second compound.
Keywords: 1H-benzimidazole-2(3H)-thione, aminosilanes, crystal structure, N—H⋯S interactions, hydrogen bonding
Abstract
Two new molecular structures, namely 1,3-bis(trimethylsilyl)-1H-benzimidazole-2(3H)-thione, C13H22N2SSi2, (2), and 1-trimethylsilyl-1H-benzimidazole-2(3H)-thione, C10H14N2SSi, (3), are reported. Both systems were derived from 1H-benzimidazole-2(3H)-thione. Noncovalent C—H⋯π interactions between the centroid of the benzmidazole system and the SiMe3 groups form helicoidal arrangements in (2). Dimerization of (3) results in the formation of R 2 2(8) rings via N—H⋯S interactions, along with parallel π–π interactions between imidazole and benzene rings.
Introduction
1H-Benzimidazole-2(3H)-thione, (1) (see Scheme 1), is a planar molecule with two substitutable acidic H atoms. The N atoms of this molecule have demonstrated the ability to form Lewis acid–base coordination compounds. Under basic conditions, the corresponding salt of (1) has been shown to react with p-block elements (O’Sullivan & Wallis, 1972 ▸).
The 1H-benzimidazole-2(3H)-thione heterocycle has been found in compounds with biological activity, such as progesterone agonists (Zhang et al., 2007 ▸). Antinematode activity was evaluated for {[(1H-benzimidazol-2-yl)thio]acetyl}piperazine (Mavrova et al., 2010 ▸), while 2-(alkylthio)benzimidazole with a β-lactam ring presented antibacterial and antifungal activities (Desai & Desai, 2006 ▸). Isomeric 2-(methylthio)benzimidazole compounds were synthesized as acyclic analogues of the HIV-1 RT inhibitor ring system (Gardiner & Loyns, 1995 ▸). More recently, isoxazole–mercaptobenzimidazole hybrids have presented analgesic and anti-inflammatory activities (Shravankumar et al., 2013 ▸). Furthermore, a wide range of biological activities have been reported for the benzimidazole fragment, such as antifungal, antibacterial, vasodilator, antispasmodic, anti-ulcer (Akkurt et al., 2012 ▸), antimicrobial (De Almeida et al., 2007 ▸), antihistamine (Mor et al., 2004 ▸), neutropic (Bakhareva et al., 1996 ▸) and analgesic (Anandarajagopal et al., 2010 ▸). Additionally, alkylsilyl-substituted benzimidazole has shown in vitro cytotoxicity, for example, 1-[3-(trimethylsilyl)propyl]benzimidazole inhibits carcinoma S180 tumour (Lukevics et al., 2001 ▸). In 2012, 1-{[dimethyl(phenyl)silyl]methyl}-3-(2-phenylethyl)-1-benzimidazol-3-ium bromide monohydrate was synthesized and its crystal structure elucidated (Akkurt et al., 2012 ▸). Silylated compounds are stable at low temperatures and, in some cases, under atmospheric conditions. Aminosilanes are soluble in nonpolar solvents, while the presence of trimethylsilyl groups increases the volatility of the organic fragments, most of which can be distilled without decomposition and, sometimes, even crystallized (Ghose & Gilchrist, 1991 ▸). Alkoxysilanes, thiosilanes and aminosilanes are stable at low temperatures, while the last class become unstable under atmospheric conditions (Colvin, 1981 ▸).
We report here the crystal structures of two new trimethylsilyl-substituted derivatives of 1H-benzimidazole-2(3H)-thione, namely 1,3-bis(trimethylsilyl)-1H-benzimidazole-2(3H)-thione, (2), and 1-trimethylsilyl-1H-benzimidazole-2(3H)-thione, (3).
Experimental
All reagents were purchased from Aldrich and were used as received. All solvents were dried before use. 1H NMR (300.13185 MHz) and 13C NMR (75.47564 MHz) analyses in CDCl3 were performed on a Bruker 300 MHz spectrometer, using TMS as the internal reference. Chemical shifts (δ) are reported in p.p.m. IR spectra were recorded on a Perkin–Elmer FT–IR 1600 spectrophotometer in the 4000–400 cm−1 range. Elemental analyses were performed in a Thermofinniga Flash 112 instrument under standard conditions.
Synthesis and crystallization
Compound (2) was obtained by mixing 1H-benzimidazole-2(3H)-thione (0.5 g, 3.3 mmol) and chlorotrimethylsilane (0.89 ml, 75.9 mg, 6.9 mmol) in triethylamine (15 ml). The reaction was kept under constant stirring and reflux for 6 h. The resulting compound was a yellow liquid (yield 92%, 1.87 g) which solidified after 24 h. Crystals of (2) suitable for X-ray diffraction analysis were collected. MS: m/z (intensity, %): 294 (M +, 100), 206 (25), 150 (11); IR (KBr, νmax, cm−1): 1623 (C=N), 1514 and 1470 (N—C—S), 1181 (Si—N), 714 and 710 (Si—C); 1H NMR (C6D6/THF, 1:1): δ AA′BB′ 7.26 (m, H4, H7), 7.04 (m, H5, H6), 0.73 (s, HMe); 13C NMR: δ 182.3 (C2), 112.2 (C4, C7), 122.6 (C5, C6), 2.5 (CMe). Elemental analysis calculated for C13H22N2SSi2: C 53.01, H 7.53, N 9.51, S 10.89%; found: C 53.03, H 7.60, N 9.60, S 10.69%.
Compound (3) was obtained from the partial hydrolysis of (2); both (2) and (3) are readily hydrolysed under atmospheric conditions. This compound was not analysed by spectroscopic techniques. However, crystals of (3) suitable for X-ray diffraction analysis were obtained from a hexane solution and a single crystal immersed in oil was analysed.
Refinement
Crystal data, data collection and structure refinement details are summarized in Table 1 ▸. H atoms were included in geometrically calculated positions, riding on the C or N atoms to which they were bonded. C—H distances were restrained to 0.93 (aromatic) or 0.96 Å (methyl) and the N—H bond length was restrained to 0.86 Å. H-atom displacement parameters were set at U iso(H) = 1.5U eq(C) for methyl H atoms and at 1.2U eq(C,N) otherwise.
Table 1. Experimental details.
| (2) | (3) | |
|---|---|---|
| Crystal data | ||
| Chemical formula | C13H22N2SSi2 | C10H14N2SSi |
| M r | 294.56 | 222.38 |
| Crystal system, space group | Orthorhombic, P212121 | Monoclinic, P21/c |
| Temperature (K) | 293 | 293 |
| a, b, c () | 10.0302(3), 10.6172(3), 16.2428(6) | 9.8057(2), 15.8032(4), 15.8658(5) |
| , , () | 90, 90, 90 | 90, 93.859(1), 90 |
| V (3) | 1729.74(10) | 2453.01(11) |
| Z | 4 | 8 |
| Radiation type | Mo K | Mo K |
| (mm1) | 0.31 | 0.33 |
| Crystal size (mm) | 0.25 0.20 0.10 0.15 (radius) | 0.20 0.20 0.15 0.15 (radius) |
| Data collection | ||
| Diffractometer | Nonius KappaCCD area-detector diffractometer | Nonius KappaCCD area-detector diffractometer |
| Absorption correction | Spherical (Dwiggins, 1975 ▸) | Spherical (Dwiggins, 1975 ▸) |
| T min, T max | 0.861, 0.862 | 0.861, 0.862 |
| No. of measured, independent and observed [I > 2(I)] reflections | 15678, 3889, 2472 | 29355, 5554, 3199 |
| R int | 0.064 | 0.096 |
| (sin /)max (1) | 0.648 | 0.649 |
| Refinement | ||
| R[F 2 > 2(F 2)], wR(F 2), S | 0.048, 0.104, 1.01 | 0.049, 0.138, 1.00 |
| No. of reflections | 3889 | 5554 |
| No. of parameters | 164 | 259 |
| H-atom treatment | H-atom parameters constrained | H-atom parameters constrained |
| max, min (e 3) | 0.17, 0.20 | 0.21, 0.24 |
| Absolute structure | Flack x parameter determined using 838 quotients, [(I +) (I )]/[(I +) + (I )] (Parsons et al., 2013 ▸) | |
| Absolute structure parameter | 0.01(7) | |
Results and discussion
Compound (2) crystallizes in the orthorhombic space group P212121. The average N1—Si1—Me10,11,12 angle is 109.0 (2)° and the average N1—Si1—Me13,14,15 angle is 109.1 (2)°. The Si—N distances of 1.809 (3) and 1.803 (3) Å are slightly longer than those reported previously for 1,3-bis(trimethylsilyl)imidazolidin-2-one [1.739 (7) Å] and 4-methyl-1,3-bis(trimethylsilyl)imidazolidin-2-one [1.745 (3) Å] (Szalay et al., 2005 ▸), which might be caused by the difference in electronegativities of the O and S atoms.
Compound (3) crystallizes with two independent molecules, A and B, in the asymmetric unit in the monoclinic space group P21/c. The average N1—Si1—Me20,21,22 angle is 108.49 (12)° and the average N11—Si2—Me23,24,25 angle is 108.66 (12)°. The Si—N distances are 1.817 (2) and 1.804 (2) Å.
Overall, compounds (2) and (3) have very similar structures, which are shown in Figs. 1 ▸ and 2 ▸, respectively. Selected bond lengths and angles are listed in Tables 2 ▸ and 3 ▸, respectively. The average C—Si bond length for both compounds is 1.847 (3) Å and the average C—Si—C angle is 109.5 (2)°, in agreement with sp 3-hybridization of the Si atoms. These values agree with those in similar structures reported previously (Wagler et al., 2010 ▸).
Figure 1.

The molecular structure of compound (2), showing the atom-numbering scheme. Displacement ellipsoids are drawn at the 30% probability level.
Figure 2.
The molecular structures of the two independent molecules of compound (3), showing the atom-numbering schemes. Displacement ellipsoids are drawn at the 30% probability level.
Table 2. Selected geometric parameters (, ) for (2) .
| Si1N1 | 1.809(3) | Si2C13 | 1.839(6) |
| Si1C11 | 1.842(5) | Si2C15 | 1.854(6) |
| Si1C12 | 1.842(5) | Si2C14 | 1.861(5) |
| Si1C10 | 1.847(5) | S1C2 | 1.669(4) |
| Si2N3 | 1.803(3) | ||
| N1Si1C11 | 109.0(2) | N3Si2C14 | 109.3(2) |
| N1Si1C12 | 109.53(19) | C13Si2C14 | 113.7(3) |
| C11Si1C12 | 113.9(3) | C15Si2C14 | 107.7(3) |
| N1Si1C10 | 108.4(2) | C2N1Si1 | 121.7(3) |
| C11Si1C10 | 109.4(3) | C8N1Si1 | 130.9(3) |
| C12Si1C10 | 106.4(3) | C2N3Si2 | 120.8(3) |
| N3Si2C13 | 109.4(2) | C9N3Si2 | 132.3(2) |
| N3Si2C15 | 108.5(2) | N1C2S1 | 125.1(3) |
| C13Si2C15 | 108.2(3) | N3C2S1 | 124.8(3) |
| C11Si1N1C2 | 70.3(4) | C14Si2N3C9 | 113.9(4) |
| C12Si1N1C2 | 55.0(4) | Si2N3C9C4 | 4.8(7) |
| C10Si1N1C2 | 170.7(3) | Si2N3C9C8 | 179.1(3) |
| C11Si1N1C8 | 113.2(4) | Si1N1C8C7 | 10.2(6) |
| C12Si1N1C8 | 121.5(4) | Si1N1C8C9 | 174.1(3) |
| C10Si1N1C8 | 5.8(4) | Si1N1C2N3 | 173.6(2) |
| C13Si2N3C2 | 59.4(4) | C8N1C2S1 | 175.3(3) |
| C15Si2N3C2 | 177.2(4) | Si1N1C2S1 | 7.5(5) |
| C14Si2N3C2 | 65.7(4) | Si2N3C2N1 | 177.2(2) |
| C13Si2N3C9 | 121.0(4) | C9N3C2S1 | 175.9(3) |
| C15Si2N3C9 | 3.2(4) | Si2N3C2S1 | 3.9(5) |
Table 3. Selected geometric parameters (, ) for (3) .
| S1C2 | 1.676(3) | S2C12 | 1.675(2) |
| Si1N1 | 1.817(2) | Si2N11 | 1.804(2) |
| Si1C22 | 1.841(3) | Si2C24 | 1.827(3) |
| Si1C20 | 1.846(3) | Si2C23 | 1.830(4) |
| Si1C21 | 1.850(3) | Si2C25 | 1.841(3) |
| N1Si1C22 | 108.72(12) | N11Si2C24 | 111.21(15) |
| N1Si1C20 | 107.62(12) | N11Si2C23 | 105.51(15) |
| C22Si1C20 | 109.24(16) | C24Si2C23 | 113.3(2) |
| N1Si1C21 | 109.12(13) | N11Si2C25 | 109.27(13) |
| C22Si1C21 | 108.81(18) | C24Si2C25 | 106.95(19) |
| C20Si1C21 | 113.23(16) | C23Si2C25 | 110.6(2) |
| C2N1Si1 | 122.00(16) | C12N11Si2 | 123.12(16) |
| C8N1Si1 | 130.56(17) | C18N11Si2 | 128.88(17) |
| N3C2S1 | 125.48(19) | N13C12S2 | 125.02(19) |
| N1C2S1 | 126.65(18) | N11C12S2 | 127.12(18) |
| C22Si1N1C2 | 176.3(2) | C24Si2N11C12 | 56.7(3) |
| C20Si1N1C2 | 65.5(2) | C23Si2N11C12 | 66.5(2) |
| C21Si1N1C2 | 57.8(2) | C25Si2N11C12 | 174.5(2) |
| C22Si1N1C8 | 1.1(3) | C24Si2N11C18 | 133.4(3) |
| C20Si1N1C8 | 117.1(2) | C23Si2N11C18 | 103.4(3) |
| C21Si1N1C8 | 119.6(2) | C25Si2N11C18 | 15.6(3) |
| C9N3C2S1 | 179.14(18) | C19N13C12S2 | 179.11(18) |
| Si1N1C2N3 | 177.32(16) | Si2N11C12N13 | 171.28(16) |
| C8N1C2S1 | 178.90(19) | C18N11C12S2 | 179.38(19) |
| Si1N1C2S1 | 3.2(3) | Si2N11C12S2 | 8.8(3) |
| Si1N1C8C9 | 177.06(17) | Si2N11C18C17 | 8.5(5) |
| Si1N1C8C7 | 3.0(4) | Si2N11C18C19 | 171.09(18) |
The C=S distances for compounds (2) and (3) range from 1.669 (4) to 1.675 (2) Å. The average N1,3—C2=S1 angle is 125.0 (3)° for (2) and the average N1,11—C2,12=S12 angle is 126.9 (18)° for (3). These angles agree with sp 2-hybridization of the C and S atoms which is typical of thiourea groups (Wagler et al., 2010 ▸). The S atom of (3) has a slight displacement of 0.007 (1) Å from the benzimidazole molecular plane, whereas in (2), the S atom is out of the plane by 0.155 (2) Å. This displacement could be caused by noncovalent intramolecular interactions between the S-atom nucleus and both Si atoms, or between the methyl H atoms and the S atom. Compound (2) presents four noncovalent C—H⋯S interactions (Table 4 ▸), with C⋯S distances ranging from 2.77 to 2.96 Å and angles ranging from 122 to 125°, which amount to less than the sum of the van der Waals radii of S and H atoms (3.25 Å; Bondi, 1964 ▸).
Table 4. Hydrogen-bond geometry (, ) for (2) .
| DHA | DH | HA | D A | DHA |
|---|---|---|---|---|
| C11H11BS1 | 0.96 | 2.96 | 3.564(7) | 122 |
| C12H12CS1 | 0.96 | 2.77 | 3.415(5) | 125 |
| C13H13BS1 | 0.96 | 2.79 | 3.423(7) | 125 |
| C14H14CS1 | 0.96 | 2.86 | 3.480(5) | 123 |
Another noncovalent intramolecular interaction (Table 5 ▸) was observed in (3), viz. C21—H21⋯S1, with a C⋯S distance of 2.83 Å and an angle of 126°, similar to that observed in (2).
Table 5. Hydrogen-bond geometry (, ) for (3) .
| DHA | DH | HA | D A | DHA |
|---|---|---|---|---|
| N3H3S2i | 0.86 | 2.52 | 3.374(2) | 170 |
| N13H13S1i | 0.86 | 2.45 | 3.282(2) | 164 |
| C21H21BS1 | 0.96 | 2.83 | 3.480(4) | 126 |
Symmetry code: (i)
.
Comparing the structures of (2) and (3), it becomes obvious that the fused rings in (2) are not completely flat. Specifically, the thiourea unit composed of atoms N1/C2/N3/S1 is offset from the molecular plane defined by the benzene ring. This is a consequence of the intramolecular noncovalent C—H⋯S interactions present in the system.
Fig. 3 ▸(a) shows the spiral arrangement of (2), which forms a linking interaction between molecules through the imidazole ring (C10—H10A⋯Cg1 = 2.94 Å; Cg1 is the centroid of the imidazole ring) and the benzene ring [C10—H10B⋯Cg2 = 2.83 Å; Cg2 is the centroid of the benzene ring at (x −
, −y +
, −z)]. These interactions form a helicoidal repeat unit of 10.03 Å, which extends along the crystallographic a axis. Fig. 3 ▸(b) presents the helix overlap of this system. A third interaction, viz. C13—H13⋯π(x +
, −y +
, −z), has a C⋯π distance of 2.77 Å, which further supports the helicoidal arrangement.
Figure 3.
(a) The spiral arrangement for (2) and (b) the overlap of the helix along the direction of the a axis.
Molecules A and B of (3) are auto-assembled by N—H⋯S interactions (N3—H3⋯S2i = 2.52 Å and N13—H13⋯S1i = 2.45 Å; see Table 5 ▸ for symmetry code). This arrangement forms a cyclic system with an
(8) hydrogen-bonding pattern (Bernstein et al., 1995 ▸) (Fig. 4 ▸). Furthermore, π–π interactions between the imidazole and benzene rings are observed in the dimerization of the compound and extend in the ab plane (Fig. 4 ▸). The distance between the ring centroids in these interactions is 3.64 Å (symmetry code: −x + 1, −y + 1, −z). There is an additional intermolecular C20—H20B⋯π(imidazole ring) interaction of 3.03 Å (symmetry code: −x + 1, y +
, −z +
) which strengthens the crystalline arrangement of (3).
Figure 4.
(a) The crystal packing diagram of (3) along the direction of the ab plane. (b) A detailed view of the formation of the
(8) hydrogen-bonding motif and the π–π stacking interactions. [Where is the origin in part (a)?]
As can be seen, the structures of (2) and (3) have similar parameters around the silyl–amine bond, but while (3) is a dimer formed by classical hydrogen bonding, the structure of (2) is a helix supported by nonclassical interactions.
Supplementary Material
Crystal structure: contains datablock(s) 2, 3, global. DOI: 10.1107/S2053229615014503/fn3201sup1.cif
Structure factors: contains datablock(s) 2. DOI: 10.1107/S2053229615014503/fn32012sup2.hkl
Structure factors: contains datablock(s) 3. DOI: 10.1107/S2053229615014503/fn32013sup3.hkl
Supporting information file. DOI: 10.1107/S2053229615014503/fn32012sup4.cml
Supporting information file. DOI: 10.1107/S2053229615014503/fn32013sup5.cml
Acknowledgments
JPM is grateful for Scholarship CVU 269487. Financial support by CONACyT (grant No. 130381) and CINVESTAV, México, is acknowledged.
References
- Akkurt, M., Küçükbay, H., Sireci, N. & Büyükgüngör, O. (2012). Acta Cryst. E68, o2718–o2719. [DOI] [PMC free article] [PubMed]
- Anandarajagopal, K., Tiwari, R. N., Venkateshan, N., Vinotha Pooshan, G. & Promwichit, P. (2010). J. Chem. Pharm. Res. 2(3), 230–236.
- Bakhareva, E., Voronkov, M., Sorokin, M., Lopyrev, V., Seredenin, S. & Gaidarov, G. M. (1996). Pharm. Chem. J. 30, 89–91.
- Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555–1573.
- Bondi, A. (1964). J. Phys. Chem. 68, 441–451.
- Colvin, E. W. (1981). Silicon in Organic Synthesis, ch. 19. London: Butterworth and Co.
- De Almeida, M. V., Cardoso, S. H., De Assis, J. V. & De Souza, M. V. N. (2007). J. Sulfur Chem. 28, 17–22.
- Desai, K. G. & Desai, K. R. (2006). Bioorg. Med. Chem. 14, 8271–8279. [DOI] [PubMed]
- Dwiggins, C. W. (1975). Acta Cryst. A31, 146–148.
- Gardiner, J. & Loyns, C. (1995). Tetrahedron, 51, 11515–11530.
- Ghose, S. & Gilchrist, T. L. (1991). J. Chem. Soc. Perkin Trans. 1, pp. 775–780.
- Lukevics, E., Arsenyan, P., Shestakova, I., Domracheva, I., Nesterova, A. & Pudova, O. (2001). Eur. J. Med. Chem. 36, 507–515. [DOI] [PubMed]
- Mavrova, A. T., Vuchev, D., Anichina, K. & Vassilev, N. (2010). Eur. J. Med. Chem. 45, 5856–5861. [DOI] [PubMed]
- Mor, M., Bordi, F., Silva, C., Rivara, S., Zuliani, V., Vacondio, F., Rivara, M., Barocelli, E., Bertoni, S., Ballabeni, V., Magnanini, F., Impicciatore, M. & Plazzi, P. V. (2004). Bioorg. Med. Chem. 12, 663–674. [DOI] [PubMed]
- Nonius (2000). COLLECT. Nonius BV, Delft, The Netherlands.
- O’Sullivan, D. G. & Wallis, A. K. (1972). J. Med. Chem. 15, 103–104. [DOI] [PubMed]
- Otwinowski, Z. & Minor, W. (1997). Methods in Enzymology, Vol. 276, Macromolecular Crystallography, Part A, edited by C. W. Carter Jr & R. M. Sweet, pp. 307–326. New York: Academic Press.
- Parsons, S., Flack, H. D. & Wagner, T. (2013). Acta Cryst. B69, 249–259. [DOI] [PMC free article] [PubMed]
- Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]
- Sheldrick, G. M. (2015). Acta Cryst. C71, 3–8.
- Shravankumar, K., Ranjith, K., Prasad, G., Niranjan, T., Srinivas, N., Mohan, R., Hanmanthu, G., Mukkanti, K., Ravinder, V. & Chandra, S. (2013). Bioorg. Med. Chem. Lett. 23, 1306–1309.
- Szalay, R., Pongor, G., Harmat, V., Böcskei, Z. & Knausz, D. (2005). J. Organomet. Chem. 690, 1498–1506.
- Wagler, J., Heine, T. & Hill, F. A. (2010). Organometallics, 29, 5607–5613.
- Zhang, P., Terefenko, E., Kern, J., Fensome, A., Trybulski, E., Unwalla, R., Wrobel, J., Lockhead, S., Zhu, Y., Cohen, J., LaCava, M., Winneker, R. & Zhang, Z. (2007). Bioorg. Med. Chem. 15, 6556–6564. [DOI] [PubMed]
- Zsolnai, L. (1997). ZORTEP. University of Heidelberg, Germany.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Crystal structure: contains datablock(s) 2, 3, global. DOI: 10.1107/S2053229615014503/fn3201sup1.cif
Structure factors: contains datablock(s) 2. DOI: 10.1107/S2053229615014503/fn32012sup2.hkl
Structure factors: contains datablock(s) 3. DOI: 10.1107/S2053229615014503/fn32013sup3.hkl
Supporting information file. DOI: 10.1107/S2053229615014503/fn32012sup4.cml
Supporting information file. DOI: 10.1107/S2053229615014503/fn32013sup5.cml



